Type 1 diabetes: treatment [sounds like]
409 results
301 - 400
Pharmacological interventions for non‐alcohol related fatty liver disease (NAFLD)
Overweight and obesity in children - Diabetic retinopathy
- Acetyl‐L‐carnitine for the treatment of diabetic peripheral neuropathy
- Metformin and second‐ or third‐generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus
- Different intensities of glycaemic control for women with gestational diabetes mellitus
- First aid glucose administration routes for symptomatic hypoglycaemia
- Fetal biometry for guiding the medical management of women with gestational diabetes mellitus for improving maternal and perinatal health
- Pregabalin for neuropathic pain in adults
- Conservative (non-surgical) treatment of obesity
- Psychological interventions for parents of children and adolescents with chronic illness
- Chronic diseases and pregnancy
- Fibrates for primary prevention of cardiovascular disease
- Treatment of chronic renal failure
Dapagliflozin reduces mortality and hospitalization rates for patients with mild heart failure and reduced ejection fraction- Adult patient access to electronic health records
- Gabapentin for chronic neuropathic pain in adults
- Multifactorial intervention improves outcomes in T2DM (Steno-2)
- Interactive telemedicine: effects on professional practice and health care outcomes
- Enzyme replacement and substrate reduction therapy for Gaucher disease
- Pressure-relieving interventions for treating diabetic foot ulcers
- Acupuncture for symptomatic gastroparesis
- Venlafaxine in the treatment of neuropathic pain
- Gene therapy for peripheral arterial disease
- PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease
- Hyperbaric oxygen therapy for chronic wounds
- Antenatal clinics: care and examinations
- Chronic pain
- Antibiotics somewhat helpful for acute conjunctivitis (NNT = 8) but most patients get better without treatment
- Use of ACEIs and ARBs in advanced chronic kidney disease does not worsen, and may improve, renal outcomes
- In patients with heart failure with a preserved ejection fraction, tirzepatide reduces hospitalizations and the need for urgent therapy but not mortality
- Amitriptyline for neuropathic pain in adults
- Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy
- Rare endocrine tumours
- Pentoxifylline for diabetic kidney disease
- Statins for women with polycystic ovary syndrome not actively trying to conceive
- Ovarian surgery for symptom relief in women with polycystic ovary syndrome
- Home glucose monitoring ineffective
- Metformin monotherapy for adults with type 2 diabetes mellitus
- Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post‐COVID‐19 condition
- Probiotic treatment for women with gestational diabetes to improve maternal and infant health and well‐being
- Mobile phone messaging for facilitating self-management of long-term illnesses: Cochrane systematic review
- Lifestyle education in type 2 diabetes
- Selenium supplementation for Hashimoto's thyroiditis: Cochrane systematic review
- GLP‐1 receptor agonists for Parkinson's disease
- Menopausal symptoms and hormone therapy
- Intravitreal steroids for macular edema in diabetes
- Weekly tirzepatide + metformin better than daily insulin degludec + metformin in decreasing A1C, weight, and hypoglycemia (SURPASS-3)
- Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients
- Organ transplant recipient in primary health care
- Oral versus intra‐vaginal imidazole and triazole anti‐fungal treatment of uncomplicated vulvovaginal candidiasis (thrush)
- Pharmacological interventions for asymptomatic carotid stenosis
- Transition of care for adolescents from paediatric services to adult health services
- Nutritional interventions for preventing and treating pressure ulcers
- Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors
- Belatacept for kidney transplant recipients
- Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease: a network meta‐analysis
- Statins for dialysis patients
- Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus
- Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes
- Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in non surgical wounds: Cochrane systematic review
- Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
- Dressings and topical agents for arterial leg ulcers
- Antenatal clinics and specialist care: consultations, referrals, treatment guidelines
- Surgery for weight loss in adults
- Natriuretic peptide‐guided treatment for the prevention of cardiovascular events in patients without heart failure
- Honey as a topical treatment for wounds
- Treatment of dyslipidaemias
- Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome
- Effects of a gluten‐reduced or gluten‐free diet for the primary prevention of cardiovascular disease
- Probiotics for vulvovaginal candidiasis in non‐pregnant women
- Patient navigator programmes for children and adolescents with chronic diseases
- Susceptibility to infections in adults
- Workplace pedometer interventions for increasing physical activity
- Erectile dysfunction
- Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome
- Ecology of the use of antimicrobial drugs
- Interventions for minimal change disease in adults with nephrotic syndrome
- Interventions for BK virus infection in kidney transplant recipients
- Immunosuppressive T‐cell antibody induction for heart transplant recipients
- Oral health education (advice and training) for people with serious mental illness
- Maternal obesity and infant outcomes
- Oral antifungal medication for toenail onychomycosis
- Cerebral infarction (ischaemic stroke)
- Cultural competence education for health professionals
- Pine bark (Pinus spp.) extract for treating chronic disorders
- Warfarin therapy
- Vaccines for measles, mumps, rubella, and varicella in children
- Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients
- Metformin for endometrial hyperplasia
- Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis
- Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery
- Fibrates for primary prevention of cardiovascular disease events
- Prehospital emergency care
- Vaccinations